EGF and glioblastoma: In GBM, EGF-mediated activation promoted PKM2 S37 phosphorylation, decreased PKM2 activity, and induced PKM2 nuclear translocation to support lactate dehydrogenase (LDHA) and glucose transporter 1 (GLUT1) expression (Figure 6) [154,158].